abstract |
Formula (I): {Wherein A is an optionally substituted phenyl or 5- or 6-in heteroaryl ring; R 1 and R 2 are selected from hydrogen and methyl; Provided that at least one of R 1 and R 2 is methyl}, or a salt, prodrug or solvate thereof. Also described are uses as GLK activators, pharmaceutical compositions containing them, and methods for their production. |